Company Filing History:
Years Active: 2004
Title: Gabi Friedrich: Innovator in Angiogenesis Modulation
Introduction
Gabi Friedrich is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of angiogenesis modulation through his innovative research and patents. His work focuses on the therapeutic potential of anti-angiogenic agents, which can have profound implications for various medical conditions.
Latest Patents
Friedrich holds a patent titled "Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor." This invention provides methods for modulating angiogenesis by administering anti-angiogenic Ang-7 polypeptides to a subject. Additionally, it includes methods of modulating angiogenesis by administering an anti-angiogenic ANG-7 nucleic acid. This patent highlights the potential of Ang-7 in therapeutic applications.
Career Highlights
Gabi Friedrich is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to explore and develop innovative solutions in the field of angiogenesis. With a focus on research and development, Friedrich has contributed to advancing medical science.
Collaborations
Friedrich has collaborated with notable colleagues, including Gustav Hagen and Maresa Wick. Their combined expertise has fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Gabi Friedrich's contributions to the field of angiogenesis modulation through his patent and work at Bayer Aktiengesellschaft underscore his role as an influential inventor. His innovative approaches have the potential to impact medical treatments significantly.